Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD).

Gabriella MacchiaBarbara Alicja Jereczek-FossaRoberta LazzariAnnamaria CerrottaFrancesco DeodatoEdy IppolitoCynthia AristeiMaria Antonietta GambacortaGiovanni ScambiaVincenzo ValentiniGabriella Ferrandina

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)

NCT04593381.

Keyphrases

phase ii study
locally advanced
radiation therapy
rectal cancer
dna damage
squamous cell carcinoma
dna repair
open label
early stage
radiation induced
cross sectional
double blind
placebo controlled
clinical trial